Donors
|
Global Fund
|
Funding the policy change
|
WHO
|
Providing evidence and technical assistance (TA), participating in the policy process, funding research
|
UNICEF
|
Providing evidence, participating in the policy process
|
Presidential Malaria Initiative/USAID
|
Funding research and participating in the policy process
|
Department for International Development (DFID) from the UK
|
Funding research and participating in the policy process
|
China
|
Providing free medicines (AL)
|
Pharmaceutical companies
|
NOVARTIS
|
Manufacturing the drug
|
Private pharmaceutical companies
|
Importing drugs
|
Public sector
|
Top management of MoH
|
Decision making
|
Technical programmes within MoH
|
Adapting and implementing the policy, participating in research processes, and disseminating evidence
|
Ministry of Finance
|
Providing funding
|
Parliamentarians
|
Disseminating evidence and information on the policy change
|
Service providers at national referral institutions
|
Providing evidence, participating in the policy process
|
Service providers at lower levels
|
Implementing the new policy
|
NDA
|
Regulating medicines
|
National Medical Store and Joint Medical Store
|
Supplying drugs
|
|
Researchers in universities
|
Providing evidence and participating in the policy process
|
Community
|
The community
|
Beneficiaries of the policy change
|
Local leaders
|
Opinion leaders at national level
|
Disseminating information on the policy change
|
Leaders at the local level
|
Disseminating information on the policy change
|
Private sectors
|
CSOs
|
Participating in policy discussions, research, advocacy, and implementation and monitoring of the new policy
|
Private practitioners
|
Implementing the new policy
|
Researchers from private research institutions
|
Providing evidence and participating in the policy process
|
Private sector—companies
|
Advocacy, publicity, donations
|